RFG Advisory »

BioCryst Pharmaceuticals shares owned by RFG Advisory

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by RFG Advisory from 13F filings

Historical chart of RFG Advisory investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by RFG Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by RFG Advisory

Quarter filed Position value Share count Share price at filing
2026-03-31 $27M 2.9M 9.52

More positions owned by RFG Advisory

Exchange Traded Concepts Tru Bluemonte Core B (BDBT)
Exchange Traded Concepts Tru Bluemonte Dynami (BLUX)
Exchange Traded Concepts Tru Bluemonte Global (BINT)
Exchange Traded Concepts Tru Bluemonte Large (BLUC)
Exchange Traded Concepts Tru Bluemonte Large (BVAL)
Exchange Traded Concepts Tru Bluemonte Large (BLGR)
Exchange Traded Concepts Tru Bluemonte Short (BLST)
Exchange Traded Concepts Tru Bluemonte Long T (BLTD)
Exchange Traded Concepts Tru Bluemonte Divers (BLUI)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Invesco Exchange Traded Fd T Rafi Us 1000 Etf (PRF)
Apple (AAPL)
Spdr Series Trust State Street Spd (SPYG)
Goldman Sachs Etf Tr Activebeta Us Lg (GSLC)
Putnam Etf Trust Focused Lar Cap (PVAL)

View all positions for RFG Advisory

Top funds holding BioCryst Pharmaceuticals

Vanguard Group
BlackRock
RA Capital Management
Deerfield Management Company
State Street Corporation
Kynam Capital Management
UBS Group
Geode Capital Management
Two Sigma Investments
Two Sigma Advisers
Nuveen
Goldman Sachs Group
Perceptive Advisors
Jennifer Ranahan
Eversept Partners

View all funds holding BioCryst Pharmaceuticals